search for




 

Safety of duodenal ampullectomy for benign periampullary tumors
Ann Hepatobiliary Pancreat Surg 2017 Aug;21(3):146-50
Published online August 31, 2017
Copyright © 2017 Ann Hepatobiliary Pancreat Surg.

Alvin Lyle Kim, and Young Il Choi

Department of Surgery, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea
Received March 21, 2017; Revised July 5, 2017; Accepted August 7, 2017.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
 Abstract
Backgrounds/Aims: Surgical resection, such as pancreaticoduodenectomy (PD), is used for treatment of benign peri-ampullary tumors, but high morbidity and mortality resulting from PD can be a huddle. The aim of this study is to suggest a safe and less invasive procedure for treatment of benign periampullary tumors. Methods: From January 2001 to September 2016, 31 patients with ampulla of Vater (AOV) tumors were reviewed retrospectively. Patients who were confirmed with malignancy through biopsy were excluded, except for one patient with malignancy and multiple underlying diseases. To investigate the safety and availability of transduodenal ampullectomy (TDA), TDA and endo-scopic papillectomy (EP) were compared. Results: There was no significant difference in the occurrence of complica-tions between the TDA group and EP group (p=0.145), and the resection margins were negative in both groups. There was no recurrence in patients who had TDA, while one patient had a recurrence after EP. Conclusions: This study suggests that TDA is as safe as EP for treating benign periampullary tumors. (Ann Hepatobiliary Pancreat Surg 2017;21:146-150)
Keywords : Periampullary tumor; Transduodenal ampullectomy; Endoscopic papillectomy

 

August 2017, 21 (3)